WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that its presentation at the Cowen 32nd Annual Health Care Conference at 10:40 am ET on March 7, 2012 will be webcast live.
